Skip to main content

01-10-2021 | EASD 2021 | Conference coverage | Video

The HARPdoc intervention for people with poor hypoglycemia awareness

Stephanie Amiel discusses the outcomes of the HARPdoc randomized trial and explains why the intervention could be so powerful for people with type 1 diabetes and reduced hypoglycemia awareness (4:12).

Read transcript

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »